Intercept Pharmaceuticals reported $39.98M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amarin AMRN:US 86.89M 3.75M
Amgen AMGN:US $ 1.33B 99M
Arrowhead Research ARWR:US $ 32.74M 1.12M
AstraZeneca AZN:LN 3.27B 209M
Biogen BIIB:US $ 572.6M 62.3M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Eli Lilly And LLY:US $ 1.63B 67.2M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Galectin Therapeutics GALT:US $ 1.88M 308K
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Moderna Inc MRNA:US 211M 57M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sangamo Biosciences SGMO:US $ 15.09M 185K
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
YTE INCY:US $ 253.28M 43.69M